These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2185077)

  • 21. Iodine- and chlorine-containing oxidation agents as hydroxylating catalysts in cytochrome P-450-dependent fatty acid hydroxylation reactions in rat liver microsomes.
    Gustafsson JA; Bergman J
    FEBS Lett; 1976 Nov; 70(1):276-80. PubMed ID: 992072
    [No Abstract]   [Full Text] [Related]  

  • 22. A critical role of protein-bound water in the catalytic cycle of cytochrome P-450 camphor.
    Di Primo C; Sligar SG; Hoa GH; Douzou P
    FEBS Lett; 1992 Nov; 312(2-3):252-4. PubMed ID: 1426259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxenoid models for enzymic hydroxylations.
    Hamilton GA; Giacin JR; Hellman TM; Snook ME; Weller JW
    Ann N Y Acad Sci; 1973; 212():4-12. PubMed ID: 4532480
    [No Abstract]   [Full Text] [Related]  

  • 24. Developmental aspects of the hepatic cytochrome P450 monooxygenase system.
    Neims AH; Warner M; Loughnan PM; Aranda JV
    Annu Rev Pharmacol Toxicol; 1976; 16():427-45. PubMed ID: 820239
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of malathion on hepatic microsomal metabolism of the male mouse.
    Stevens JT
    Pharmacology; 1974; 11(6):330-5. PubMed ID: 4413070
    [No Abstract]   [Full Text] [Related]  

  • 26. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K; Kittelmann M; Lütz S
    Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase).
    Tyndale RF; Kalow W; Inaba T
    Br J Clin Pharmacol; 1991 Jun; 31(6):655-60. PubMed ID: 1867960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of CYP2D6 in oxidative metabolism of cinnarizine and flunarizine in human liver microsomes.
    Narimatsu S; Kariya S; Isozaki S; Ohmori S; Kitada M; Hosokawa S; Masubuchi Y; Suzuki T
    Biochem Biophys Res Commun; 1993 Jun; 193(3):1262-8. PubMed ID: 8323546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assimilation of propane and properties of propan monooxygenase from Rhodococcus erythropolis 3/89].
    Kulikova AK; Bezborodov AM
    Prikl Biokhim Mikrobiol; 2001; 37(2):186-9. PubMed ID: 11357423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P-450 mixed function oxygenases in placental tissue: metabolism of endogenous and exogenous compounds.
    Chao ST; Juchau MR
    Proc West Pharmacol Soc; 1980; 23():3-7. PubMed ID: 6773060
    [No Abstract]   [Full Text] [Related]  

  • 31. Occurrence of aromatic methyl migration (NIH-shift) during oxidation of p-methylanisole by hemin-thiolester complex as a cytochrome P-450 model.
    Sakurai H; Hatayama E; Fujitani K; Kato H
    Biochem Biophys Res Commun; 1982 Oct; 108(4):1649-54. PubMed ID: 7181912
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the metabolism of parathion by a rat liver reconstituted mixed-function oxidase enzyme system and by a system containing cumene hydroperoxide and purified rat liver cytochrome P-450.
    Yoshihara S; Neal RA
    Drug Metab Dispos; 1977; 5(2):191-7. PubMed ID: 15813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.
    Damkier P; Hansen LL; Brosen K
    Br J Clin Pharmacol; 1999 Dec; 48(6):829-38. PubMed ID: 10594487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P-450 dependent biotransformation: some recent developments. Introductory remarks: cytochromne P-450 mixed function oxygenases.
    Finlayson MJ; Bellward GD
    Proc West Pharmacol Soc; 1980; 23():1-2. PubMed ID: 7403109
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytochrome P-450 rotamers control mixed-function oxygenation in reconstituted membranes. Rotational diffusion studied by delayed fluorescence depolarization.
    Greinert R; Finch SA; Stier A
    Xenobiotica; 1982 Nov; 12(11):717-26. PubMed ID: 7168192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of human liver cytochrome P450s involved in the microsomal metabolism of the antihistaminic drug loratadine.
    Yumibe N; Huie K; Chen KJ; Clement RP; Cayen MN
    Int Arch Allergy Immunol; 1995; 107(1-3):420. PubMed ID: 7613198
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on cytochrome P-450-dependent lipid hydroperoxide reduction.
    Lindstrom TD; Aust SD
    Arch Biochem Biophys; 1984 Aug; 233(1):80-7. PubMed ID: 6431911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of vitamin D2 on the monooxygenase activity of the rat liver].
    Sushko LI; Abakumov GZ; Lukienko PI; Voronov GG
    Vopr Med Khim; 1985; 31(4):108-11. PubMed ID: 3876645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of NADPH oxidation and related drug oxidation in liver microsomes by zinc.
    Chvapil M; Ludwig JC; Sipes IG; Misiorowski RL
    Biochem Pharmacol; 1976 Aug; 25(15):1787-91. PubMed ID: 8050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.